This study also showed that monocytes from SLE patients had a higher expression of IRGs and higher inflammasome activation than healthy donors, and that this response was further potentiated by IFN-α treatment (Liu et al, 2017). Here, IFNA1 is linked to systemic lupus erythematosus.